Cancer Research UK logo.
SearchDonate
  • Search

A trial to see the effects of bevacizumab and pazopanib in renal cell cancer

Overview

Cancer types:

Kidney cancer, Renal cell cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is looking at the effect of 2 drugs called bevacizumab and pazopanib. It is for people who have kidney cancer that has got worse despite having other treatment.

Recruitment start: 23 October 2009

Recruitment end: 30 April 2012

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Tim Eisen

Supported by

Cambridge University Hospitals NHS Foundation Trust

Experimental Cancer Medicine Centre (ECMC)

GlaxoSmithKline (GSK)

Last reviewed: 29 April 2012

CRUK internal database number: 6049

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.